VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q3 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,049,893 | $53,523,545 | 17.09% |
| Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $40,429,128 | 16.12% |
| Kynam Capital Management, LP | 1,302,407 | $66,396,709 | 10.86% |
| RA Capital Management | 7,891,254 | $402,296,129 | 7.92% |
| COMMODORE CAPITAL LP | 1,100,000 | $56,078,000 | 6.56% |
| GREAT POINT PARTNERS LLC | 531,211 | $27,081,137 | 4.93% |
| ACUTA CAPITAL PARTNERS, LLC | 121,022 | $6,169,702 | 4.14% |
| Frazier Life Sciences Management, L.P. | 1,164,405 | $59,361,367 | 3.94% |
| Novo Holdings A/S | 845,000 | $43,078,100 | 3.18% |
| BRAIDWELL LP | 1,619,553 | $82,564,812 | 2.61% |
| Soleus Capital Management, L.P. | 499,650 | $25,472,157 | 2.35% |
| Ghost Tree Capital, LLC | 140,000 | $7,137,200 | 2.35% |
| Perceptive Advisors | 1,342,751 | $68,453,446 | 2.28% |
| Parkman Healthcare Partners LLC | 238,132 | $12,139,969 | 2.22% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,294,000 | 2.16% |
| Cormorant Asset Management, LP | 665,000 | $33,901,700 | 1.98% |
| Nicholas Investment Partners, LP | 460,008 | $23,451,208 | 1.75% |
| Pier Capital, LLC | 203,728 | $10,386,053 | 1.67% |
| Avidity Partners Management LP | 756,165 | $38,549,292 | 1.55% |
| Opaleye Management Inc. | 90,000 | $4,588,200 | 1.49% |
External links
This page lists VAXCYTE INC's shareholders in Q3 2023. To view VAXCYTE INC's shareholder history, click here.